期刊文献+

Safety issues in hormonal therapy 被引量:4

Safety issues in hormonal therapy
下载PDF
导出
摘要 Safety issues in hormonal therapy have been discussed in recent years especially in the field of hormone replacement therapy(HRT).The most important study Women's Health Initiative(WHI)has been stopped in 2002 due to increased risk of venous thromboembolism,myocardial infarction,stroke and breast cancer.This overview will concentrate on these main risks.There are options of different HRT regimens to minimize these risks.Especially plausible is the use of minimal dosages of transdermal administration avoiding first liver passage which should reduce hepatic and cardiovascular risks,which,however,is not based on placebo-controlled studies.For breast cancer development,first fear of most women,further research on the two main mechanisms are most importantproliferation effects and conditions for potential genotoxic estrogen metabolites.To individualize hormonal therapy also preexisting risks have to be considered,and with early start,within a"window of opportunity",most patients will benefit from HRT if indicated. Safety issues in hormonal therapy have been discussed in recent years especially in the field of hormone replacement therapy (HRT). The most important study Women's Health Initiative (WHI) has been stopped in 2002 due to increased risk of venous thromboembolism, myocardial infarction, stroke and breast cancer. This overview will concentrate on these main risks. There are options of different HRT regimens to minimize these risks. Especially plausible is the use of minimal dosages of transdermal administration avoiding first liver passage which should reduce hepatic and cardiovascular risks, which, however, is not based on placebo-controlled studies. For breast cancer development, first fear of most women, further research on the two main mechanisms are most important- proliferation effects and conditions for potential genotoxic estrogen metabolites. To individualize hormonal therapy also preexisting risks have to be considered, and with early start, within a "window of oooortunitv", most natients will benefit frnm HRT if inrllr^t~A
出处 《首都医科大学学报》 CAS 2013年第4期483-491,共9页 Journal of Capital Medical University
关键词 激素治疗 治疗方法 临床分析 静脉血栓栓塞 hormonal therapy safety issues breast cancer
  • 相关文献

参考文献55

  • 1Marchbanks P A, McDonaldJ A, Wilson H G, et al. Oral contraceptives and the risk of breast cancer[J]. N EnglJ Med, 2002,346(26) :2025-2032.
  • 2Hannaford PC, Selvaraj S, Elliott AM, et al. Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study[J]. BMJ, 2007,335 (7621) :651.
  • 3WHI Investigators. Risks and benefits of estrogen plus pro?gestin in healthy postmenopausal women[J].JAM A , 2002, 288(3) :321-333.
  • 4WHI Steering Committee. Effects of conjugated equine es?trogen in postmenopausal women with hysterectomy[J].JA?MA, 2004,291(14) :1701-1712.
  • 5WHI Investigators. Estrogen plus progestin and the risk of coronary heart disease[J]. N EnglJ Med, 2003,349 ( 6) : 523-534.
  • 6WHI Investigators. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since meno?pause[J].JAMA, 2007,297 (l3) : 1465- 1477.
  • 7Ortmann 0 ( Leitlinienkoordination). Hormontherapie in der Peri-und Postmenopause. Kurzversion der interdisziplinaren S3-Leitlinie[J]. Frauenarzt, 2009,50(11) :840-851.
  • 8WHI Investigators. Conjugated equine estrogens and coro?nary heart disease[J]. Arch Intern Med, 2006, 166 ( 3 ) : 357-365.
  • 9Moorjani S, Dupont A, Labrie F. Changes in plasma lipo?protein and apolipoprotein composition in relation to oral vesrsus transdermal administration of estrogens[J].J Clin Endocrinol Metab, 1991,73(2) :373-379.
  • 10Scarabin P Y, Alhenc-Gelas M, PIu-Bureau G, et al. Effects of oral and transdermal estrogen/progesterone regi?mens on blood coagulation and fibrinolysis in postmenopaus?al women. A randomized controlled trial[J]. Arterioscler Thromb Vase BioI, 1997,17 (11) :3071- 3078.

同被引文献39

引证文献4

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部